SACUBITRIL / VALSARTAN IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION: COMPARATIVE PROFILE OF NT-PROBNP AND BNP

被引：0
|
作者：
Ajello, L. [1 ]
Romano, G. [1 ]
Agnese, V. [1 ]
Bellavia, D. [1 ]
Di Gesaro, G. [1 ]
Falletta, C. [1 ]
La Franca, E. [1 ]
Mina, C. [1 ]
Storniolo, S. [1 ]
Clemenza, F. [1 ]
机构：
[1] ISMETT, Palermo, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2019年 / 21卷 / 0E期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P251
引用
收藏
页码：E223 / E224
页数：2
相关论文
共 50 条
  • [1] Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction
    Rorth, Rasmus
    Jhund, Pardeep S.
    Yilmaz, Mehmet B.
    Kristensen, Soren Lund
    Welsh, Paul
    Desai, Akshay S.
    Kober, Lars
    Prescott, Margaret F.
    Rouleau, Jean L.
    Solomon, Scott D.
    Swedberg, Karl
    Zile, Michael R.
    Packer, Milton
    McMurray, John J., V
    CIRCULATION-HEART FAILURE, 2020, 13 (02) : E006541
  • [2] NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction TRANSITION Study
    Pascual-Figal, Domingo
    Wachter, Rolf
    Senni, Michele
    Bao, Weibin
    Noe, Adele
    Schwende, Heike
    Butylin, Dmytro
    Prescott, Margaret F.
    JACC-HEART FAILURE, 2020, 8 (10) : 822 - 833
  • [3] Original Effect of sacubitril-valsartan on left ventricular remodeling and NT-proBNP in patients with heart failure complicated with hypertension and reduced ejection fraction
    Xie, Bingqing
    Gao, Quancai
    Wang, Yibo
    Du, Jiangxin
    He, Yaoli
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (05): : 1935 - 1944
  • [4] Deconvolution of BNP and NT-proBNP Immunoreactivities by Mass Spectrometry in Heart Failure and Sacubitril/Valsartan Treatment
    Nougue, Helene
    Michel, Thibault
    Picard, Francois
    Lassus, Johan
    Sadoune, Malha
    Laribi, Said
    Cohen-Solal, Alain
    Logeart, Damien
    Launay, Jean-Marie
    Vodovar, Nicolas
    CLINICAL CHEMISTRY, 2023, 69 (04) : 350 - 362
  • [5] NT-proBNP for functional capacity assessment in patients with heart failure with reduced ejection fraction
    Daniel Gomes, D.
    Cunha, G.
    Ferreira, J.
    Maltes, S.
    Rocha, B.
    Albuquerque, F.
    Paiva, M.
    Santos, R.
    Gama, F.
    Freitas, P.
    Moreno, L.
    Durazzo, A.
    Mendes, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 80 - 81
  • [6] Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction
    Salah, Khibar
    Stienen, Susan
    Pinto, Yigal M.
    Eurlings, Luc W.
    Metra, Marco
    Bayes-Genis, Antoni
    Verdiani, Valerio
    Tijssen, Jan G. P.
    Kok, Wouter E.
    HEART, 2019, 105 (15) : 1182 - +
  • [7] Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction
    Dewan, Pooja
    Docherty, Kieran F.
    McMurray, John J., V
    KOREAN CIRCULATION JOURNAL, 2019, 49 (06) : 469 - 484
  • [8] NT-proBNP in Heart Failure With Preserved Ejection Fraction
    Tanaka, Atsushi
    Node, Koichi
    JACC-HEART FAILURE, 2020, 8 (07) : 596 - 597
  • [9] Prognostic value of NT-ProBNP/BNP ratio in patients with heart failure and reduced ejection fraction using sacubitril-valsartan: systematic review and post hoc analysis of PARADIGM-HF Trial
    Eduardo Pitthan, E.
    Hirakata, V. N.
    Barbisan, J. N.
    Rodrigues, C. G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 245 - 245
  • [10] NT-proBNP is a potential mediator between reduced ejection fraction and depression in patients with heart failure
    Zuzarte, Pedro
    Scola, Gustavo
    Duong, Angela
    Kostiw, Kari
    Figueira, Maria L.
    Costa-Vitali, Atilio
    JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 104 : 8 - 15
12345